Can PET data differentiate Alzheimer's disease from vascular dementia?

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 252-261

  Nagata, Ken ^a   Maruya, Hiroshi ^a   Yuya, Hiromichi ^b   Terashi, Hiroo ^c   Mito, Yasunori ^a   Kato, Haruhisa ^a   Sato, Mika ^a   Satoh, Yuichi ^a   Watahiki, Yasuhito ^a   Hirata, Yutaka ^a   Yokoyama, Eriko ^d   Hatazawa, Jun ^a  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b Shiranuka Medical Office   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d Akita Prefectural Center of Rehabilitation and Psychiatric Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN 15;

ADULT; AGED; ALZHEIMER DISEASE; BLOOD VESSEL REACTIVITY; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FRONTAL LOBE; HEMODYNAMICS; HUMAN; METABOLIC RATE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; OCCIPITAL CORTEX; PARIETAL LOBE; PATHOGENESIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

EID: 0034017654     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06375.x     Document Type: Conference Paper

References (40)

1. 1. TOMLINSON, B.E. et al. 1970. Observation on the brains of demented old people. J. Neurol. Sci. 11: 205.
2. 2. GRUBB, R. et al. 1977. Cerebral blood flow, oxygen utilization and blood volume in dementia. Neurology 27: 905-910.
3. 3. FRACKOWIAK, R.S.J. et al. 1981. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104: 753-778.
4. 4. FRIEDLAND, R.P. et al. 1985. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci. Lett. 53: 235-240.
5. 99mTc-HM-PAO in the investigation of dementia. J. Neurol. Neurosurg. Psychiatry 50: 1101-1109.
6. 6. RAPOPORT, S.T. 1990. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical view. Cerebrovasc. Brain Metab. Rev. 3: 297-335.
7. 7. SALMON, E. et al. 1994. Differential diagnosis of Alzheimer's disease with PET. J. Nucl. Med. 35: 391-398.
8. 8. FUKUYAMA, H. et al. 1994. Altered cerebral energy metabolism in Alzheimer's disease. a PET study. J. Nucl. Med. 35: 1-6.
9. 9. MIELKE, R. et al. 1994. HMPAO SPECT and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur. J. Nucl. Med. 21: 1052-1060.
10. 10. TERAYAMA, Y. et al. 1992. Patterns of cerebral hypoperfusion compared among demented and nondemented patients with stroke. Stroke 23(5): 686-692.
11. 11. SABRI, O. et al. 1999. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangipathy. Stroke 30(3): 556-566.
12. 12. NAGATA, K. et al. 1997. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826: 272-281.
13. 13. MORI, E. et al. 1985. Usefulness of Japanese version of the Mini-Mental State test in neurological patients. Jpn. J. Neuropsychiatry 1: 82-90.
14. 14. HONMA, A. et al. 1992. Development of a Japanese version of Alzheimer's disease assessment scale. Jpn. J. Geriatr. Psychiatry 5: 647-655.
15. 15. MCKHANN, G. et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA working group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 5: 2801-2808.
16. 16. MORRIS, J.C. 1993. The clinical dementia rating: current version and screening rules. Neurology 43: 2412-2414.
17. 17. HACHINSKI, V.C. 1974. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 2: 207-210.
18. 18. LOEB, C. et al. 1983. Diagnostic evaluation of degenerative and vascular dementia. Stroke 14: 399-401.
19. 19. LAMMERTSMA, A.A. & T. JONES. 1983. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method. J. Cereb. Blood Flow Metab. 3: 416-424.
20. 20. IIDA, H. et al. 1989. Design of evaluation of HEADTOME IV: a whole body PET. IEEE Trans. Nucl. Sci. 36: 1006-1010.
21. 21. NAGATA, K. et al. 1993. Effects of fasudil hydrochloride on cerebral blood flow in patients with chronic cerebral infarction. Clin. Neuropharmacol. 16(6): 501-510.
22. 22. SALMON, E. et al. 1994. Differential diagnosis of Alzheimer's disease with PET. J. Nucl. Med. 35(3): 391-398.
23. 23. HERHIOLZ, K. 1995. FDG PET and differential diagnosis of dementia. Alzheimer Dis. Assoc. Disord. 9(1): 6-16.
24. 24. HEISS, M.R. 1988. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. J. Neural Transm. Suppl. 53: 237-250.
25. 25. TOHGI, H. et al. 1998. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 40(39): 131-137.
26. 15O continuous inhalation technique: In Computerized Tomography. J.M. Cailler & G. Salamon, Eds.: 231-237. Springer. Berlin.
27. 27. Baron, J.C. et al. 1981. Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. Stroke 12: 454-459.
28. 28. TSUTSUMI, K. & K. NAGATA. 1998. Misery perfusion syndrome in the chronic stage of cerebral infarction. Jpn. J. Stroke 20: 489-499.
29. 29. DE REUCK, J. et al. 1998. Positron emission tomography in vascular dementia. J. Neurol. Sci. 154(1): 55-61.
30. 30. DE REUCK, J. et al. 1999. Acetazolamide vascular reactivity in vascular dementia: a positron emission tomographic study. Eur. Neurol. 41(1): 31-36.
31. 31. SHOJI, M. et al. 1990. The amyloid-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res. 530: 113-116.
32. 32. KAWAI, M. et al. 1993. Degeneration of amyloid precursor protein-containing smooth muscle cells in cerebral amyloid angiopathy. Brain Res. 623: 142-146.
33. 33. TAGLIAVINI, F. et al. 1991. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab. Invest. 62: 761-767.
34. 34. YAMAGUCHI, H. et al. 1992. Beta amyloid is fally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am. J. Pathol. 141: 249-259.
35. 35. WISNIEWSKI, H. et al. 1991. Ultrastructural studies of the cell forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathology 84: 117-127.
36. 36. JAGUAST, W.J. et al. 1991. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J. Cereb. Blood Flow. Metab. 11: 323-330.
37. 37. KONDOH, Y. et al. 1997. Dynamic FDG-PET study in probable Alzheimer's disease. Ann. N.Y. Acad. Sci. 826: 406-409.
38. 38. DE LA TORRE, J.C. & T. MUSSIVAND. 1993. Can disturbed brain microcirculation use Alzheimer's disease. Neurol. Res. 15: 146-153.
39. 39. KALARIA, R.N. et al. 1992. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebovasc. Brain Metab. Rev. 4: 226-260.
40. 40. DE LA TORRE, J.C. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neuro. Biobehav. Rev. 18(3): 397-401.